1011 On Other Exchanges
Symbol
Exchange
Hong Kong

china nt pharma group co ltd (1011) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NT PHARMA GROUP CO LTD (1011)
\

Related News

No related news articles were found.

china nt pharma group co ltd (1011) Related Businessweek News

No Related Businessweek News Found

china nt pharma group co ltd (1011) Details

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China and internationally. It operates through two segments, Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment is involved in the production and sale of NT branded products and generic drugs. The Miacalcic segment sells branded Miacalcic injectable and nasal spray branded products for the treatment of bone pains caused by osteolysis and lower bone mass, osteoporosis, Paget's disease, hypercalcemia, and reflex sympathetic dystrophy syndrome. This segment also sub-licenses intellectual property and distribution rights. The company is also involved in the trading of prescription medicines; and provision of logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Shanghai, the People's Republic of China.

665 Employees
Last Reported Date: 04/29/19
Founded in 1995

china nt pharma group co ltd (1011) Top Compensated Officers

Co-Founder, Chairman & CEO
Total Annual Compensation: CNY8.9M
Senior VP, GM of Manufacturing & Supply Chain...
Total Annual Compensation: CNY2.1M
Executive Director
Total Annual Compensation: CNY221.0K
Compensation as of Fiscal Year 2018.
china nt pharma group co ltd
China Nt Pharma Group Company Limited Omits to Pay Final Dividend for the Year 2018

The Board of China NT Pharma Group Company Limited does not recommended the payment of a final dividend for the year (2017: 0.35 cents per ordinary share) to the shareholders.

China NT Pharma Group Company Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2018

China NT Pharma Group Company Limited reported audited consolidated earnings results for the year ended December 31, 2018. For the year, the company reported revenue of HKD 571,521,000 against HKD 604,846,000 a year ago. Loss for the year was HKD 963,762,000 against profit of HKD 161,629,000 a year ago. Basic loss earnings per share was 12.2 cents against 9.4 cents a year ago. Basic loss per share was 61.16 cents against earnings of 10.72 cents a year ago. Diluted loss per share was 61.16 cents against earnings of 9.12 cents a year ago. Basic loss per share from continuing operations was 38.05 cents against earnings of 13.89 cents a year ago. Diluted loss per share from continuing operations was 38.05 cents against earnings of 11.98 cents a year ago.

China NT Pharma Group Company Limited to Report Fiscal Year 2018 Results on Mar 29, 2019

China NT Pharma Group Company Limited announced that they will report fiscal year 2018 results on Mar 29, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHINA NT PHARMA GROUP CO LTD, please visit www.ntpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.